AAO-HNSF Clinical Practice Guideline Development
Public Comment – Clinical Practice Guideline: Allergic Rhinitis
Tuesday, August 19 - Tuesday, September 2
A draft of the AAO-HNSF Clinical Practice Guideline: Allergic Rhinitis is now available for public comment. The comment period will run from Tuesday, August 19 thru Tuesday, September 2. During this time, members of the public are encouraged to review the guideline and provide comments. While the goal of this phase is to obtain public comment, we also encourge other stakeholders to participate, if they so desire. The purpose of the comment period is to ensure that all stakeholders have an opportunity to review the guideline recommendations, action statement profiles, and supporting text prior to publication.
Please remember that this guideline is intended for all clinicians in any setting who are likely to diagnose and manage patients with Allergic Rhinitis. The target population is inclusive of both adults and children presenting with Allergic Rhinitis.
We ask that non-healthcare professionals, specifically, to pay close attention to the evidence profile of each action statement. Action statement profiles contain informtion regarding the role of patient preferences, benefit/harm assessment, and intentional vagueness, which may be most relevant to members of the public.
To participate in the public comment, users must agree not
to distribute or share the draft guideline with any other individuals or organizations prior to the official publication of the guideline, and must disclose any conflicts of interest. Following conflict of interest disclosure, a PDF of the guideline document will then become available, and users will receive a link to the comment page.